An exciting study is underway that could potentially lead to new treatments for metastatic prostate cancer, cancer that has spread to other areas of the body, at the world-class Centre for Cancer Biology in Adelaide.
Leading this research are experts Professor Greg Goodall and Dr Phillip Gregory who are committed and passionate about finding a cure for this terrible disease.
Recently, they’ve identified a new molecular pathway which is likely to control whether a prostate cancer cell remains benign or becomes more aggressive and metastasises.
“We discovered this protein (Quaking) could drive prostate cancer cells to become more aggressive and there was an indication that this could be linked with prostate cancer that spreads through the body,” Dr Gregory explained.
Initial results suggest the level of Quaking increases as tumours become more aggressive and that this is associated with a patient’s chances of survival.
“The reality is most people don’t die from cancer, they die from the metastasis that comes from the cancer.
This important discovery could lead to developing treatments to stop not just prostate cancer from spreading to other areas of the body, but also other common cancers like breast and colon cancer.
“Now we’re looking to extend this study to a second patient cohort to see if the trend holds.”
“What we hope is that this protein will give clinicians a better diagnostic indication of whether a prostate cancer cell is likely to become aggressive and metastasise. We hope that this protein might end up being an important therapeutic avenue to target in the future.”
This protein could prove crucial in helping doctors pick the best treatment avenue for their patient, based on if their cancer is aggressive or not.
Will you support this promising research that could stop the spread of prostate cancer?
You can help progress this new development into clinical trials sooner and save more lives. Donate today.